Junshik Hong

27PUBLICATIONS
89CO-AUTHORS
Regenerative medicine (incl. stem cells)Labour, migration and developmentHaematological tumoursMedical virologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Jun 02, 2026
Selinexor Plus Ruxolitinib in Janus Kinase Inhibitor-Naïve Myelofibrosis: Phase III SENTRY Trial.

|Mar 11, 2026
Persistent and emerging cancer risks after migration: Evidence from North and South Korean cohorts.

Junshik Hong, Kyeong Jin Kim, Jimi Choi

|Dec 25, 2025
Real-world experience with tisagenlecleucel for the treatment of relapsed or refractory diffuse large B-cell lymphoma in Korea.

Dong Hyun Kim, Soyean Kwon, Seungah Cha

|Dec 04, 2025
Clinical Outcomes of Low-Grade Cytomegalovirus DNAemia in Hematopoietic Stem Cell Transplantation Recipients Receiving Letermovir Prophylaxis.

Jung Soo Son, Eun-Jeong Jeong, Hyeon Jae Jo

|Jul 14, 2025
Azacitidine followed by R-GDP in transplant-ineligible relapsed/refractory diffuse large B-cell lymphoma: preliminary results from a multicenter, phase II study.

Dong Hyun Kim, Jee Hyun Kong, Junshik Hong

|Jun 25, 2025
The role of ASXL1, SRSF2, and EZH2 mutations in chromatin dysregulation of myelodysplastic neoplasia and acute myeloid leukemia.

Hosang Yu, Junshik Hong, Dong-Yeop Shin

Pageof 5

Frequent Collaborators

8 joint publications

Sung-Soo Yoon

7 joint publications

Soo-Mee Bang

6 joint publications

Dong-Yeop Shin

6 joint publications

Ja Min Byun